Abstract
Background
Interventional closure of paravalvular leaks (PVL) by plug implantation has emerged as an alternative to surgical correction, which is associated with high mortality rates for re-operation. To date, data on procedural efficacy and clinical outcome after transcatheter closure is sparse. We present our experience with interventional PVL closure at our site.
Methods and results
From 08/2014 to 10/2016 ten patients (three women, seven men) at high surgical risk for repeat surgery underwent interventional PVL closure for severe paravalvular regurgitation (PVR) in 14 procedures at our site. Nine procedures (64%) were performed for mitral PVLs, five procedures were performed for aortic PVLs (36%). Mean age of the population treated was 70 ± 8.6 years and mean log. Euro-Score I was 27.4 ± 14.9%. All patients were treated by implantation of Amplatzer Vascular Plug III occluders. All aortic PVLs were treated using a retrograde transfemoral access, mitral PVLs were treated using either a transseptal (8/9) or transapical access (1/9) under 3-dimensional transesophageal echocardiographic and fluoroscopic guidance. Indication for PVL closure was the presence of severe heart failure symptoms in all patients (NYHA class III/IV, n = 14) and additional mechanical hemolytic anemia (n = 5) with a need for transfusion. Interventional closure of PVL was completely successful in 12 procedures (85%), partially successful in one procedure due to inability to cross the defect with a wire (7.5%) and failed in one of 14 procedures due to inability of plug deployment in a very large defect (7.5%). One patient in a critical clinical condition died within 24 h after procedure due to progressive cardiogenic shock after procedural failure and refusal of a surgical treatment by cardiac surgeons. After interventional treatment clinical success with improvement in NYHA functional class or hemolysis was achieved in 93% (13/14). Median NYHA class improved significantly from 4 prior to procedure to 2 after PVL closure (p = 0.0005). Severe PVR was significantly reduced to mild in six patients and to moderate in three patients after procedure (p = 0.001). Complications included one hemothorax after transapical access and one pseudoaneurysm after transfemoral arterial access. In-hospital mortality rate was 20% (2/10) in this high-risk population. After hospital discharge no death occurred during 30-day follow-up, one patient died during 1-year follow-up after PVL closure.
Conclusion
In this single-center series interventional PVL closure appears promising for patients at high surgical risk with symptomatic paravalvular regurgitation. Gaining experience in interventional PVL closure at specialized sites will further improve safety and efficacy of this relatively new treatment option. All patients should be treated within large clinical registries to gain more data on mid- and long-term efficacy of transcatheter PVL closure.
Similar content being viewed by others
References
Kliger C, Eiros R, Isasti G, Einhorn B, Jelnin V, Cohen H, Kronzon I, Perk G, Fontana GP, Ruiz CE (2013) Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure. Eur Heart J 34:638–649
Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the veterans affairs randomized trial. J Am Coll Cardiol 36:1152–1158
Ionescu A, Fraser AG, Butchart EG (2003) Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart 89:1316–1321
Carlos E, Ruiz YD, Vladimir J, Itzhak K, Bryce N, Einhorn H, Cohen A (2012) Percutaneous closure of paravalvular leaks. In: Eeckhout E, Serruys PW, Wijns W, Sambeck AV, Palma MV RD (eds) Percutaneous interventional cardiovascular medicine: the PCR-EAPCI textbook, vol III, Chap. 41. Europa √©d, pp 263–274. https://www.pcronline.com/eurointervention/textbook/pcr-textbook/table-of-contents/
Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P (1999) Natural history of early aortic paraprosthetic regurgitation: a 5-year follow-up. Am Heart J 138:351–357
de Almeida Brandao CM, Pomerantzeff PM, Souza LR, Tarasoutchi F, Grimberg M, Ramires JA, Almeida de Oliveira S (2002) Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction. Eur J Cardiothorac Surg 22:922–926
Echevarria JR, Bernal JM, Rabasa JM, Morales D, Revilla Y, Revuelta JM (1991) Reoperation for bioprosthetic valve dysfunction. A decade of clinical experience. Eur J Cardiothorac Surg 5:523–526
Exposito V, Garcia-Camarero T, Bernal JM, Arnaiz E, Sarralde A, Garcia I, Berrazueta JR, Revuelta JM (2009) Repeat mitral valve replacement: 30-years’ experience. Rev Esp Cardiol 62:929–932
Akins CW, Bitondo JM, Hilgenberg AD, Vlahakes GJ, Madsen JC, MacGillivray TE (2005) Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks. J Heart Valve Dis 14:792–799
Choi JW, Hwang HY, Kim KH, Kim KB, Ahn H (2013) Long-term results of surgical correction for mitral paravalvular leak: repair versus re-replacement. J Heart Valve Dis 22:682–687
Ruiz CE, Jelnin V, Kronzon I, Dudiy Y, Del Valle-Fernandez R, Einhorn BN, Chiam PT, Martinez C, Eiros R, Roubin G, Cohen HA (2011) Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. J Am Coll Cardiol 58:2210–2217
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, ESC Scientific Document Group (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739–2791. https://doi.org/10.1093/eurheartj/ehx391.2017
Garcia-Borbolla Fernandez R, Sancho Jaldon M, Calle Perez G, Gomez Menchero AE, de Zayas Rueda R, Arana Granado R, Marante Fuertes E, Cabeza Lainez P (2009) Percutaneous treatment of mitral valve periprosthetic leakage. An alternative to high-risk surgery? Rev Esp Cardiol 62:438–441
Hein R, Wunderlich N, Robertson G, Wilson N, Sievert H (2006) Catheter closure of paravalvular leak. EuroIntervention 2:318–325
Hourihan M, Perry SB, Mandell VS, Keane JF, Rome JJ, Bittl JA, Lock JE (1992) Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol 20:1371–1377
Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG (2006) Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 68:528–533
Brockenbrough EG, Braunwald E (1960) A new technic for left ventricular angiocardiography and transseptal left heart catheterization. Am J Cardiol 6:1062–1064
Nietlispach F, Johnson M, Moss RR, Wijesinghe N, Gurvitch R, Tay EL, Thompson C, Webb JG (2010) Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC Cardiovasc Interv 3:759–765
Sorajja P, Cabalka AK, Hagler DJ, Rihal CS (2011) Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv 4:314–321
Calvert PA, Northridge DB, Malik IS, Shapiro L, Ludman P, Qureshi SA, Mullen M, Henderson R, Turner M, Been M, Walsh KP, Casserly I, Morrison L, Walker NL, Thomson J, Spence MS, Mahadevan VS, Hoye A, MacCarthy PA, Daniels MJ, Clift P, Davies WR, Adamson PD, Morgan G, Aggarwal SK, Ismail Y, Ormerod JO, Khan HR, Chandran SS, de Giovanni J, Rana BS, Ormerod O, Hildick-Smith D (2016) Percutaneous device closure of paravalvular leak: Combined experience from the United Kingdom and Ireland. Circulation 134:934–944
Sorajja P, Cabalka AK, Hagler DJ, Reeder GS, Chandrasekaran K, Cetta F, Rihal CS (2007) Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv 70:815–823
Sorajja P, Cabalka AK, Hagler DJ, Rihal CS (2011) Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation. J Am Coll Cardiol 58:2218–2224
Sorajja P, Cabalka AK, Hagler DJ, Rihal CS (2014) The learning curve in percutaneous repair of paravalvular prosthetic regurgitation: an analysis of 200 cases. JACC Cardiovasc Interv 7:521–529
Seidler T, Hunlich M, Puls M, Hasenfuss G, Jacobshagen C (2017) Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol 106:183–191
Alonso-Briales JH, Munoz-Garcia AJ, Jimenez-Navarro MF, Dominguez-Franco AJ, Melero-Tejedor JM, Rodriguez-Bailon I, Hernandez-Garcia JM, de Teresa-Galvan E (2009) Closure of perivalvular leaks using an Amplatzer occluder. Rev Esp Cardiol 62:442–446
Garcia E, Arzamendi D, Jimenez-Quevedo P, Sarnago F, Marti G, Sanchez-Recalde A, Lasa-Larraya G, Sancho M, Iniguez A, Goicolea J, Garcia-San Roman K, Alonso-Briales JH, Molina E, Calabuig J, Freixa X, Berenguer A, Valdes-Chavarri M, Vazquez N, Diaz JF, Cruz-Gonzalez I (2017) Outcomes and predictors of success and complications for paravalvular leak closure: an analysis of the SpanisH real-wOrld paravalvular LEaks closure (HOLE) registry. EuroIntervention 12:1962–1968
Jelnin V, Dudiy Y, Einhorn BN, Kronzon I, Cohen HA, Ruiz CE (2011) Clinical experience with percutaneous left ventricular transapical access for interventions in structural heart defects a safe access and secure exit. JACC Cardiovasc Interv 4:868–874
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest.
Rights and permissions
About this article
Cite this article
Werner, N., Zeymer, U., Fraiture, B. et al. Interventional treatment of paravalvular regurgitation by plug implantation following prosthetic valve replacement: a single-center experience. Clin Res Cardiol 107, 1160–1169 (2018). https://doi.org/10.1007/s00392-018-1290-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-018-1290-7